in contrast to the actions typical of beta blocking agents , intravenous sotalol prolonged the effective refractory periods of the ventricles and accessory pathways and reduced the ventricular response to atrial fibrillation in the patients with the wolff-parkinson-white syndrome .
C0037707
sotalol
C0042510
ventricular